ADEA Washington Update

ADEA Participates in ONDCP Roundtable to Discuss Drug Use and Abuse

(HHS, Department of Justice, Opioid Abuse, Prescription Drug Abuse) Permanent link   All Posts

PillsAndPadADEA staff met with White House officials and others on Aug. 2 to discuss drug use and abuse as part of a roundtable discussion hosted by the White House Office of National Drug Control Policy (ONDCP). In July, ONDCP released an interim report by President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis. The report contains nine policy recommendations aimed at stemming the nation’s growing opioid crisis, which currently claims more than 100 lives every day.

The commission points to overprescribing of opioids in the health care system as a foundational cause of the crisis and recognizes the role dental schools can play in enhancing prescriber education. The report calls on the President to amend the Controlled Substance Act to require all Drug Enforcement Administration (DEA) registrants to take a course in the proper treatment of pain and recommends drawing on “the assistance of medical and dental schools across the country” to enhance prevention through prescriber education.

The report recognizes Massachusetts Governor Charlie Baker’s administration for “work[ing] with the medical and dental schools in that state and the Medical Society to develop core competencies related to opioids and [substance use disorders] that all graduating students are expected to learn and put into practice.”

Among the commission’s other recommendations are:

  • Rapidly increase drug treatment capacity.
  • Enhance access to medication-assisted treatment.
  • Support state legislation to allow naloxone dispensing via standing orders.
  • Prioritize funding to staunch the flow of synthetic opioids into the United States.
  • Enhance interstate data sharing.
  • Enforce the Mental Health Parity and Addiction Equity Act.

Following the meeting, ADEA President and CEO, Dr. Rick Valachovic sent a letter to ONDCP informing the office that “academic dentistry is equally concerned and committed to solutions to address the prescription drug and opioid abuse problem in the United States.”

Duggan ad 2013